- Home
- RVMD vs LNTH Comparison
RVMD vs LNTH Comparison
Compare RVMD & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVMD
- LNTH
- Stock Information
- Founded
- RVMD 2014
- LNTH 1956
- Country
- RVMD United States
- LNTH United States
- Employees
- RVMD N/A
- LNTH N/A
- Industry
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- RVMD Health Care
- LNTH Health Care
- Exchange
- RVMD Nasdaq
- LNTH Nasdaq
- Market Cap
- RVMD 7.4B
- LNTH 7.5B
- IPO Year
- RVMD 2020
- LNTH 2015
- Fundamental
- Price
- RVMD $39.40
- LNTH $75.56
- Analyst Decision
- RVMD Strong Buy
- LNTH Strong Buy
- Analyst Count
- RVMD 12
- LNTH 5
- Target Price
- RVMD $68.67
- LNTH $133.80
- AVG Volume (30 Days)
- RVMD 2.0M
- LNTH 1.5M
- Earning Date
- RVMD 05-07-2025
- LNTH 05-07-2025
- Dividend Yield
- RVMD N/A
- LNTH N/A
- EPS Growth
- RVMD N/A
- LNTH N/A
- EPS
- RVMD N/A
- LNTH 3.53
- Revenue
- RVMD N/A
- LNTH $1,536,699,000.00
- Revenue This Year
- RVMD N/A
- LNTH $4.63
- Revenue Next Year
- RVMD $241.39
- LNTH $9.35
- P/E Ratio
- RVMD N/A
- LNTH $21.40
- Revenue Growth
- RVMD N/A
- LNTH 12.53
- 52 Week Low
- RVMD $29.17
- LNTH $73.11
- 52 Week High
- RVMD $62.40
- LNTH $126.89
- Technical
- Relative Strength Index (RSI)
- RVMD 51.81
- LNTH 32.65
- Support Level
- RVMD $36.53
- LNTH $73.75
- Resistance Level
- RVMD $40.00
- LNTH $76.34
- Average True Range (ATR)
- RVMD 1.80
- LNTH 2.50
- MACD
- RVMD -0.21
- LNTH -0.09
- Stochastic Oscillator
- RVMD 47.28
- LNTH 23.36
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.